Medicare Enrolled

Dr. Sandra Gibiezaite, M.D.

Endocrinology · Paterson, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
703 MAIN ST, Paterson, NJ 07503
9737542476
In practice since 2010 (16 years)
NPI: 1255651873 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gibiezaite from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gibiezaite? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gibiezaite

Dr. Sandra Gibiezaite is an endocrinology specialist in Paterson, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Gibiezaite performed 281 Medicare services across 168 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gibiezaite received a total of $8,778 from 35 pharmaceutical and/or device companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gibiezaite is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 281 Medicare services $8,778 industry payments

Medicare Practice Summary

Medicare Utilization ↗
281
Medicare services
Bottom 14% in NJ for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
168
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
133 $89 $362
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
57 $64 $239
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
50 $131 $487
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
30 $106 $454
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $126 $550
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,778
Total received (2018-2024)
Avg $1,254/year across 7 years
Top 19% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,778 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,163
2023
$1,301
2022
$899
2021
$575
2020
$584
2019
$2,222
2018
$1,034

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,050
Lilly USA, LLC
$271
Amgen Inc.
$260
Abbott Laboratories
$86
Novo Nordisk Inc
$58
Corcept Therapeutics
$52
ABBVIE INC.
$52
SANOFI-AVENTIS U.S. LLC
$50
Mannkind Corporation
$48
Amneal Pharmaceuticals LLC
$47
PFIZER INC.
$36
Radius Health, Inc.
$34
Tolmar, Inc.
$30
Dexcom, Inc.
$20
Xeris Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$17
Neurocrine Biosciences, Inc.
$17
Kyowa Kirin, Inc.
$16
Top 3 companies account for 73.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic MiniMed, Inc.
$2,107
Medtronic, Inc.
$1,295
Lilly USA, LLC
$1,072
SANOFI-AVENTIS U.S. LLC
$444
Novo Nordisk Inc
$424
Boehringer Ingelheim Pharmaceuticals, Inc.
$371
Amgen Inc.
$367
MannKind Corporation
$307
Abbott Laboratories
$272
Dexcom, Inc.
$236
AstraZeneca Pharmaceuticals LP
$217
Merck Sharp & Dohme Corporation
$195
Amneal Pharmaceuticals LLC
$185
Insulet Corporation
$179
Shire North American Group Inc
$174
Corcept Therapeutics
$146
Mannkind Corporation
$109
Xeris Pharmaceuticals, Inc.
$105
GlaxoSmithKline, LLC.
$79
PFIZER INC.
$66
Horizon Therapeutics plc
$55
ABBVIE INC.
$52
Alexion Pharmaceuticals, Inc.
$47
Radius Health, Inc.
$34
Kyowa Kirin, Inc.
$33
CeQur Corporation
$30
AbbVie Inc.
$30
Ascendis Pharma Inc
$30
Tolmar, Inc.
$30
Neurocrine Biosciences, Inc.
$17
Daiichi Sankyo Inc.
$15
Celgene Corporation
$15
DEXCOM, INC.
$14
IBSA Pharma Inc.
$14
Ipsen Biopharmaceuticals, Inc
$12
Top 3 companies account for 51.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASMANEX · BAQSIMI · BASAGLAR · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · JANUVIA · JARDIANCE · JATENZO · Korlym · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · Macrilen · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Norditropin · Omnipod · Otezla · Ozempic · Prolia · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SOLITAIRE X · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Sogroya · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tymlos · UNITHROID
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Paterson?
Compare endocrinologists in the Paterson area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
643
Per 100K population
124.1
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gibiezaite is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of NJ peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gibiezaite experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gibiezaite performed 133 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gibiezaite receive payments from pharmaceutical companies?
Yes. Dr. Gibiezaite received a total of $8,778 from 35 companies across 339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gibiezaite's costs compare to other endocrinologists in Paterson?
Dr. Gibiezaite's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gibiezaite) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →